What is Delek US Holdings, Inc.'s earnings per share (EPS)?

Delek US Holdings, Inc. (DK) reported diluted earnings per share of -$0.38 for fiscal year 2025. This represents a 95.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Delek US Holdings, Inc. (DK) Financials

Trailing 12 months to June 30, 2026

Revenue $12.1B +11.4% YoY

Net Income $224.5M +129.2% YoY

EPS (Diluted) $3.58 +129.2% YoY

Free Cash Flow $681.3M +184.4% YoY

Market Cap $4.7B as of Oct 12, 2026

Price / Sales 0.4x on $12.1B revenue, trailing 12 months to June 30, 2026

Price / Earnings 21.1x on $224.5M net income, trailing 12 months to June 30, 2026

Price / Book 11.2x on $422.7M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 12, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 5, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DK SEC filings page.

Delek US Holdings, Inc. (DK) reported $12.1B in revenue over the twelve months to Jun 30, 2026, up 11.4% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI DK FY2025 2026-10-04

2025 restored refinery profitability, but rising debt and heavy reinvestment left little cash after operations.

The margin rebound was real: gross margin moved from -0.4% in FY2024 to 5.7%, and operating margin recovered from -4.2% to 2.8%. Yet interest expense rose to $345M, leaving the company with a net loss of $23M; operating improvement therefore did not fully reach shareholders.

Cash conversion was the central constraint in FY2025: operating cash flow reached $536M, but capital spending consumed nearly all of it, leaving only $6M of free cash flow. Compared with FY2023, when free cash flow was $621M, the pattern indicates a business whose accounting recovery required substantial reinvestment.

The balance-sheet posture became more leveraged even as operations recovered: debt-to-equity increased from 2.7x in FY2023 to 5.9x in FY2025, while the current ratio fell to 0.8x. That combination points to less short-term financial flexibility and a larger share of operating value claimed by creditors.

Financial Health Signals

Financial Health Score 17/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Delek US Holdings, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Delek US Holdings, Inc. has an operating margin of 2.8%, meaning the company retains $3 of operating profit per $100 of revenue. This below-average margin results in a low score of 17/100, suggesting thin profitability after operating expenses. This is up from -4.2% the prior year.

Growth

Delek US Holdings, Inc.'s revenue declined 9.5% year-over-year, from $11.9B to $10.7B. This contraction results in a growth score of 4/100.

Leverage

Delek US Holdings, Inc. has elevated debt relative to equity (D/E of 5.89), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 17/100, reflecting increased financial risk.

Liquidity

Delek US Holdings, Inc.'s current ratio of 0.82 is below the typical benchmark, resulting in a score of 23/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

While Delek US Holdings, Inc. generated $535.8M in operating cash flow, capex of $529.5M consumed most of it, leaving $6.3M in free cash flow. This results in a low score of 25/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Delek US Holdings, Inc. posts a -4.2% return on equity (ROE), meaning it loses $4 for every $100 of shareholders' equity. This results in a returns score of 17/100. This is up from -97.4% the prior year.

Altman Z-Score Grey Zone

2.02

Delek US Holdings, Inc. scores 2.02, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral

5/9

Delek US Holdings, Inc. passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

N/A

Delek US Holdings, Inc. reported a net loss of $22.8M while generating $535.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.

Interest Coverage At Risk

0.87x

Delek US Holdings, Inc. earns $0.87 in operating income for every $1 of interest expense ($301.0M vs $345.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$4.1B

YoY+47.8%

QoQ+54.0%

5Y CAGR+13.3%

10Y CAGR+13.5%

Delek US Holdings, Inc. generated $4.1B in revenue in Q2 2026. This represents an increase of 47.8% from the same quarter a year earlier. Against the prior quarter it is up 54.0%.

EBITDA

$418.1M

YoY+589.9%

QoQ+650.1%

5Y CAGR+91.8%

10Y CAGR+26.3%

Delek US Holdings, Inc.'s EBITDA was $418.1M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 589.9% from the same quarter a year earlier. Against the prior quarter it is up 650.1%.

Net Income

$169.5M

YoY+259.3%

QoQ+184.2%

Delek US Holdings, Inc. reported $169.5M in net income in Q2 2026. This represents an increase of 259.3% from the same quarter a year earlier. Against the prior quarter it is up 184.2%.

EPS (Diluted)

$2.71

YoY+254.0%

QoQ+181.1%

Delek US Holdings, Inc. earned $2.71 per diluted share (EPS) in Q2 2026. This represents an increase of 254.0% from the same quarter a year earlier. Against the prior quarter it is up 181.1%.

Cash & Balance Sheet

Free Cash Flow

$89.1M

YoY+177.9%

QoQ-67.4%

5Y CAGR+1.0%

Delek US Holdings, Inc. generated $89.1M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 177.9% from the same quarter a year earlier. Against the prior quarter it is down 67.4%.

Cash & Debt

$628.6M

YoY+2.1%

QoQ+0.7%

5Y CAGR-5.5%

10Y CAGR+5.6%

Delek US Holdings, Inc. held $628.6M in cash against $3.2B in long-term debt as of Q2 2026.

Dividends Per Share

$0.26

YoY0.0%

QoQ0.0%

Delek US Holdings, Inc. paid $0.26 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

61M

YoY+1.8%

QoQ-0.1%

5Y CAGR-3.7%

Delek US Holdings, Inc. had 61M shares outstanding in Q2 2026. This represents an increase of 1.8% from the same quarter a year earlier. Against the prior quarter it is down 0.1%.

Margins & Returns

Gross Margin

8.9%

YoY+7.0pp

QoQ+13.8pp

Delek US Holdings, Inc.'s gross margin was 8.9% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 7.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 13.8 percentage points.

Operating Margin

7.4%

YoY+8.6pp

QoQ+14.2pp

5Y change+9.7pp

10Y change+6.4pp

Delek US Holdings, Inc.'s operating margin was 7.4% in Q2 2026, reflecting core business profitability. This is up 8.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 14.2 percentage points.

Net Margin

4.2%

YoY+8.0pp

QoQ+11.7pp

5Y change+6.7pp

10Y change+4.8pp

Delek US Holdings, Inc.'s net profit margin was 4.2% in Q2 2026, showing the share of revenue converted to profit. This is up 8.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.7 percentage points.

Return on Equity

40.1%

YoY+76.2pp

QoQ+106.8pp

5Y change+45.8pp

Delek US Holdings, Inc.'s ROE was 40.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 76.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 106.8 percentage points.

Capital Allocation

Capital Expenditures

$173.8M

YoY+4.8%

QoQ-7.4%

5Y CAGR+15.5%

Delek US Holdings, Inc. invested $173.8M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 4.8% from the same quarter a year earlier. Against the prior quarter it is down 7.4%.

R&D Spending

Not reported for Q2 2026.

Share Buybacks

Not reported for Q2 2026.

DK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DK quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Revenue	$12.1B	$10.7B-9.5%	$11.9B-28.0%	$16.5B-16.8%	$19.8B+86.0%	$10.6B+45.8%	$7.3B-21.5%	$9.3B-9.1%	$10.2B+40.8%	$7.3B+73.1%	$4.2B-1.7%	$4.3B
Cost of Revenue	N/A	$10.1B-15.0%	$11.9B-25.3%	$15.9B-16.5%	$19.1B+83.2%	$10.4B+37.5%	$7.6B-10.1%	$8.4B-9.2%	$9.3B+35.5%	$6.8B+64.1%	$4.2B-1.7%	$4.2B
Gross Profit	N/A	$612.1M+1520.2%	-$43.1M-107.9%	$548.5M-26.6%	$747.7M+198.5%	$250.5M+196.0%	-$261.0M-129.3%	$890.1M-8.5%	$972.8M+125.3%	$431.7M+1257.5%	$31.8M-5.4%	$33.6M
SG&A Expenses	N/A	$269.5M+6.6%	$252.8M-7.1%	$272.0M-13.3%	$313.7M+56.5%	$200.4M-14.6%	$234.6M-14.6%	$274.7M+10.9%	$247.6M+40.8%	$175.9M+65.8%	$106.1M+5.5%	$100.6M
Operating Income	$583.4M	$301.0M+161.2%	-$491.5M-300.9%	$244.7M-46.5%	$457.5M+1418.4%	-$34.7M+95.3%	-$732.3M-248.8%	$492.3M-19.5%	$611.9M+239.4%	$180.3M+466.5%	-$49.2M-171.6%	$68.7M
EBITDA	N/A	$698.8M+697.3%	-$117.0M-120.0%	$584.2M-20.2%	$732.5M+218.6%	$229.9M+149.5%	-$464.7M-167.7%	$686.6M-15.4%	$811.3M+143.2%	$333.6M+396.4%	$67.2M-61.5%	$174.7M
Interest Expense	N/A	$345.3M+10.3%	$313.0M+409.8%	$61.4M+162.4%	$23.4M+29.3%	$18.1M-86.0%	$129.0M-1.6%	$131.1M+4.1%	$125.9M+34.2%	$93.8M+72.4%	$54.4M+4.4%	$52.1M
Income Tax	N/A	-$6.8M+93.7%	-$107.9M-3496.7%	-$3.0M-105.3%	$56.4M+234.3%	-$42.0M+78.3%	-$193.6M-370.0%	$71.7M-29.6%	$101.9M+449.0%	-$29.2M+83.0%	-$171.5M-985.4%	-$15.8M
Net Income	$224.5M	-$22.8M+95.9%	-$560.4M-2930.3%	$19.8M-92.3%	$257.1M+300.4%	-$128.3M+79.0%	-$611.4M-296.8%	$310.6M-8.7%	$340.1M+17.8%	$288.8M+287.9%	-$153.7M-892.3%	$19.4M
EPS (Basic)	N/A	-$0.38+95.7%	-$8.77-3023.3%	$0.30-91.7%	$3.63+309.8%	-$1.73+79.2%	-$8.31-302.7%	$4.10-0.2%	$4.11+1.7%	$4.04+262.2%	-$2.49-878.1%	$0.32
EPS (Diluted)	$3.58	-$0.38+95.7%	-$8.77-3023.3%	$0.30-91.6%	$3.59+307.5%	-$1.73+79.2%	-$8.31-304.7%	$4.06+2.8%	$3.95-1.2%	$4.00+260.6%	-$2.49-878.1%	$0.32
Diluted Shares (Avg)	N/A	61M-5.0%	64M-2.3%	65M-8.5%	72M-3.3%	74M+0.5%	74M-3.9%	77M-11.7%	87M+20.0%	72M+16.8%	62M+1.0%	61M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Revenue	$4.1B+47.8%	$2.7B+0.4%	$2.4B+2.3%	$2.9B-5.1%	$2.8B-16.4%	$2.6B-15.5%	$2.4B-39.8%	$3.0B-34.3%
Cost of Revenue	$3.7B+37.2%	$2.8B+2.9%	N/A	$2.5B-18.7%	$2.7B-17.6%	$2.7B-10.8%	N/A	$3.1B-29.6%
Gross Profit	$365.1M+599.4%	-$130.2M-104.4%	N/A	$397.7M+2068.8%	$52.2M+210.7%	-$63.7M-167.1%	N/A	-$20.2M-107.3%
SG&A Expenses	$56.7M-26.0%	$44.0M-28.5%	N/A	$76.8M+9.1%	$76.6M+27.2%	$61.5M+0.8%	N/A	$70.4M+4.0%
Operating Income	$302.4M+1002.7%	-$179.3M-42.5%	$164.6M+140.8%	$295.7M+342.6%	-$33.5M-828.3%	-$125.8M-530.8%	-$403.4M-180.3%	-$121.9M-157.5%
EBITDA	$418.1M+589.9%	-$76.0M-210.2%	$265.7M+186.5%	$397.0M+1768.1%	$60.6M-34.8%	-$24.5M-120.3%	-$307.1M-415.3%	-$23.8M-107.9%
Interest Expense	$100.1M+16.5%	$84.5M+0.5%	N/A	$93.1M+18.1%	$85.9M+472.7%	$84.1M+409.7%	N/A	$78.8M+377.6%
Income Tax	$41.8M+396.5%	-$58.2M-58.2%	N/A	$39.9M+199.0%	-$14.1M-60.2%	-$36.8M-384.2%	N/A	-$40.3M-238.5%
Net Income	$169.5M+259.3%	-$201.3M-16.6%	$78.3M+118.9%	$178.0M+331.8%	-$106.4M-186.0%	-$172.7M-429.8%	-$413.8M-150.9%	-$76.8M-159.7%
EPS (Basic)	$2.76+256.8%	-$3.34-20.1%	$1.32+120.2%	$2.96+346.7%	-$1.76-203.4%	-$2.78-445.1%	-$6.53-149.2%	-$1.20-160.6%
EPS (Diluted)	$2.71+254.0%	-$3.34-20.1%	$1.28+119.6%	$2.93+344.2%	-$1.76-203.4%	-$2.78-445.1%	-$6.53-149.2%	-$1.20-160.9%
Diluted Shares (Avg)	62M+3.3%	60M-3.0%	N/A	61M-4.9%	61M-5.8%	62M-3.0%	N/A	64M-2.1%

Not reported in any period shown, so not listed: R&D Expenses.

DK Balance Sheet

DK quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Total Assets	$6.8B+2.7%	$6.7B-7.1%	$7.2B-12.5%	$8.2B+20.3%	$6.8B+11.1%	$6.1B-12.6%	$7.0B+21.8%	$5.8B-2.9%	$5.9B+99.2%	$3.0B	N/A
Current Assets	$2.1B-11.3%	$2.3B-12.5%	$2.7B-28.3%	$3.7B+23.1%	$3.0B+31.3%	$2.3B-22.4%	$3.0B+22.4%	$2.4B-7.3%	$2.6B+87.0%	$1.4B	N/A
Cash & Equivalents	$625.8M-14.9%	$735.6M-10.5%	$821.8M-2.3%	$841.3M-1.8%	$856.5M+8.8%	$787.5M-17.6%	$955.3M-11.5%	$1.1B+15.8%	$931.8M+35.2%	$689.2M+140.0%	$287.2M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$726.0M-18.7%	$893.2M-5.1%	$941.2M-38.0%	$1.5B+20.4%	$1.3B+73.2%	$727.7M-23.1%	$946.7M+39.7%	$677.9M-16.1%	$808.4M+106.0%	$392.4M	N/A
Accounts Receivable	$648.7M+5.0%	$617.6M-21.2%	$783.7M-36.5%	$1.2B+58.9%	$776.6M+47.1%	$527.9M-33.4%	$792.6M+54.1%	$514.4M-11.2%	$579.6M+118.0%	$265.9M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$475.3M0.0%	$475.3M-30.9%	$687.5M-2.1%	$702.3M-3.8%	$729.7M0.0%	$729.7M-14.7%	$855.7M-0.2%	$857.8M+5.0%	$816.6M+6593.4%	$12.2M0.0%	$12.2M
Total Liabilities	$6.3B+3.4%	$6.1B-2.0%	$6.2B-12.8%	$7.1B+22.8%	$5.8B+15.6%	$5.0B-3.2%	$5.2B+31.1%	$4.0B-0.5%	$4.0B+120.9%	$1.8B	N/A
Current Liabilities	$2.5B+0.5%	$2.5B-6.3%	$2.7B-13.0%	$3.1B-1.3%	$3.1B+64.3%	$1.9B-19.2%	$2.4B+41.6%	$1.7B-37.7%	$2.7B+185.7%	$935.2M	N/A
Non-Current Liabilities	$3.8B+5.5%	$3.6B+1.3%	$3.5B-12.6%	$4.0B+51.1%	$2.7B-14.0%	$3.1B+9.9%	$2.8B+23.4%	$2.3B+76.2%	$1.3B+50.7%	$862.1M	N/A
Long-Term Debt	$3.2B+17.0%	$2.8B+7.8%	$2.6B-14.2%	$3.0B+40.1%	$2.1B-8.2%	$2.3B+14.0%	$2.0B+16.0%	$1.8B+100.1%	$875.4M+17.0%	$748.5M	N/A
Total Equity	$547.3M-4.9%	$575.2M-40.1%	$959.7M-10.3%	$1.1B+5.5%	$1.0B-9.2%	$1.1B-39.2%	$1.8B+1.5%	$1.8B-7.9%	$2.0B+66.1%	$1.2B-12.7%	$1.4B
Retained Earnings	-$311.1M-51.2%	-$205.7M-147.8%	$430.0M-15.3%	$507.9M+32.0%	$384.7M-26.3%	$522.0M-56.7%	$1.2B+22.8%	$981.8M+27.9%	$767.8M+47.0%	$522.3M	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Total Assets	$7.6B+6.8%	$7.6B+10.0%	$6.8B+2.7%	$7.1B+0.7%	$7.1B+1.8%	$6.9B-4.2%	$6.7B-7.1%	$7.0B-10.7%
Current Assets	$2.6B+12.1%	$2.6B+19.5%	$2.1B-11.3%	$2.3B-8.5%	$2.3B-7.2%	$2.2B-18.2%	$2.3B-12.5%	$2.6B-23.1%
Cash & Equivalents	$628.6M+2.1%	$624.1M0.0%	$625.8M-14.9%	$630.9M-39.2%	$615.5M-6.4%	$623.8M-17.2%	$735.6M-10.5%	$1.0B+15.1%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$999.3M+16.1%	$931.0M+9.2%	$726.0M-18.7%	$769.3M-15.9%	$860.9M-14.8%	$852.5M-17.9%	$893.2M-5.1%	$915.0M-22.4%
Accounts Receivable	$866.3M+16.5%	$942.7M+45.3%	$648.7M+5.0%	$667.2M+18.8%	$743.4M-3.6%	$648.8M-22.0%	$617.6M-21.2%	$561.6M-51.9%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$475.3M0.0%	$475.3M0.0%	$475.3M0.0%	$475.3M-30.9%	$475.3M-34.8%	$475.3M-34.8%	$475.3M-30.9%	$687.5M-7.6%
Total Liabilities	$7.1B+5.2%	$7.3B+12.6%	$6.3B+3.4%	$6.6B+7.8%	$6.8B+13.6%	$6.5B+5.0%	$6.1B-2.0%	$6.2B-8.3%
Current Liabilities	$3.4B+17.4%	$3.5B+34.8%	$2.5B+0.5%	$2.7B+10.1%	$2.9B+13.3%	$2.6B-0.6%	$2.5B-6.3%	$2.5B-17.8%
Non-Current Liabilities	$3.7B-3.9%	$3.8B-2.3%	$3.8B+5.5%	$3.9B+8.4%	$3.9B+13.9%	$3.9B+9.1%	$3.6B+1.3%	$3.6B-2.5%
Long-Term Debt	$3.2B+2.9%	$3.2B+4.9%	$3.2B+17.0%	$3.2B+14.0%	$3.1B+26.1%	$3.0B+21.9%	$2.8B+7.8%	$2.8B+6.6%
Total Equity	$422.7M+43.3%	$302.0M-29.7%	$547.3M-4.9%	$444.8M-49.2%	$294.9M-70.0%	$429.4M-58.5%	$575.2M-40.1%	$875.4M-24.3%
Retained Earnings	-$387.8M+25.4%	-$528.6M-33.7%	-$311.1M-51.2%	-$363.1M-258.9%	-$519.8M-258.4%	-$395.4M-203.6%	-$205.7M-147.8%	$228.5M-63.1%

DK Cash Flow Statement

DK quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Operating Cash Flow	$1.3B	$535.8M+902.1%	-$66.8M-106.6%	$1.0B+138.3%	$425.3M+14.5%	$371.4M+231.3%	-$282.9M-149.2%	$575.2M+2.7%	$560.3M+75.3%	$319.7M+28.9%	$248.0M+37.8%	$180.0M
Depreciation & Amortization	N/A	$397.8M+6.2%	$374.5M+10.3%	$339.5M+23.5%	$275.0M+3.9%	$264.6M-1.1%	$267.6M+37.7%	$194.3M-2.6%	$199.4M+30.1%	$153.3M+31.7%	$116.4M+9.8%	$106.0M
Stock-Based Compensation	N/A	$86.7M+156.5%	$33.8M+22.9%	$27.5M-5.5%	$29.1M+18.3%	$24.6M+7.9%	$22.8M-11.6%	$25.8M+20.6%	$21.4M+22.3%	$17.5M+6.7%	$16.4M-2.4%	$16.8M
Capital Expenditures	$589.5M	$529.5M+23.8%	$427.7M+9.0%	$392.5M+40.1%	$280.2M+26.1%	$222.2M-17.5%	$269.4M-34.8%	$413.0M+28.3%	$322.0M+87.2%	$172.0M+271.5%	$46.3M-75.3%	$187.7M
Free Cash Flow	$681.3M	$6.3M+101.3%	-$494.5M-179.6%	$621.1M+328.0%	$145.1M-2.7%	$149.2M+127.0%	-$552.3M-440.5%	$162.2M-31.9%	$238.3M+61.3%	$147.7M-26.8%	$201.7M+2719.5%	-$7.7M
Investing Cash Flow	-$586.8M	-$697.9M-189.0%	-$241.5M+40.8%	-$408.0M+56.2%	-$931.6M-422.2%	-$178.4M+6.7%	-$191.3M+72.3%	-$691.3M-451.7%	-$125.3M-433.2%	$37.6M-81.3%	$200.7M+143.6%	-$460.4M
Financing Cash Flow	-$670.9M	$52.3M-76.4%	$221.7M+135.5%	-$624.7M-227.2%	$491.1M+496.0%	-$124.0M-140.5%	$306.4M+3978.5%	-$7.9M+97.3%	-$297.6M-184.5%	-$104.6M-69.5%	-$61.7M-144.5%	$138.5M
Dividends Paid	$61.8M	$62.0M-3.4%	$64.2M+6.5%	$60.3M+40.9%	$42.8M	$0-100.0%	$69.1M-20.4%	$86.8M+8.4%	$80.1M+82.0%	$44.0M+17.3%	$37.5M+1.1%	$37.1M
Share Buybacks	N/A	N/A	$0	$0-100.0%	$64.0M	$0-100.0%	$1.9M-98.9%	$178.1M-51.2%	$365.3M+1361.2%	$25.0M+316.7%	$6.0M-85.8%	$42.2M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Operating Cash Flow	$262.9M+411.5%	$461.1M+838.9%	$502.8M+407.5%	$44.0M+303.7%	$51.4M+206.2%	-$62.4M-137.4%	-$163.5M-280.1%	-$21.6M-105.0%
Depreciation & Amortization	$115.7M+23.0%	$103.3M+2.0%	$101.1M+5.0%	$101.3M+3.3%	$94.1M+6.4%	$101.3M+10.5%	$96.3M+14.2%	$98.1M+11.9%
Stock-Based Compensation	$5.2M-14.8%	$7.4M+7.2%	N/A	N/A	$6.1M	$6.9M-4.2%	N/A	N/A
Capital Expenditures	$173.8M+4.8%	$187.7M+38.3%	$120.0M-37.0%	$108.0M-9.2%	$165.8M+107.5%	$135.7M+254.3%	$190.5M+163.9%	$119.0M+178.7%
Free Cash Flow	$89.1M+177.9%	$273.4M+238.0%	$382.8M+208.1%	-$64.0M+54.5%	-$114.4M+10.8%	-$198.1M-254.3%	-$354.0M-2003.2%	-$140.6M-136.1%
Investing Cash Flow	-$176.2M-8.1%	-$190.3M+39.5%	-$116.9M+45.8%	-$103.4M-231.9%	-$163.0M-160.8%	-$314.6M-656.3%	-$215.8M-211.0%	$78.4M+233.6%
Financing Cash Flow	-$82.2M-179.6%	-$272.5M-202.8%	-$391.0M-605.8%	$74.8M-76.8%	$103.3M+570.8%	$265.2M+236.8%	$77.3M+176.6%	$322.9M+209.9%
Dividends Paid	$15.6M+0.6%	$15.6M-1.9%	$15.3M-5.0%	$15.3M-6.7%	$15.5M-3.1%	$15.9M+1.3%	$16.1M+4.5%	$16.4M+7.9%

Not reported in any period shown, so not listed: Share Buybacks.

DK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

DK quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K
Gross Margin	5.7%+6.1pp	-0.4%-3.7pp	3.3%-0.4pp	3.8%+1.4pp	2.4%+5.9pp	-3.6%-13.1pp	9.6%+0.1pp	9.5%+3.6pp	5.9%+5.2pp	0.8%0.0pp	0.8%
Operating Margin	2.8%+7.0pp	-4.2%-5.6pp	1.5%-0.8pp	2.3%+2.6pp	-0.3%+9.7pp	-10.0%-15.3pp	5.3%-0.7pp	6.0%+3.5pp	2.5%+3.6pp	-1.2%-2.8pp	1.6%
Net Margin	-0.2%+4.5pp	-4.7%-4.9pp	0.1%-1.2pp	1.3%+2.5pp	-1.2%+7.2pp	-8.4%-11.7pp	3.3%0.0pp	3.3%-0.6pp	4.0%+7.6pp	-3.7%-4.1pp	0.4%
Return on Equity	-4.2%+93.3pp	-97.4%-99.5pp	2.1%-22.0pp	24.0%+36.7pp	-12.7%+42.1pp	-54.8%-71.7pp	16.9%-1.9pp	18.8%+4.1pp	14.7%+27.7pp	-13.0%-14.4pp	1.4%
Return on Assets	-0.3%+8.1pp	-8.4%-8.7pp	0.3%-2.9pp	3.1%+5.0pp	-1.9%+8.1pp	-10.0%-14.4pp	4.4%-1.5pp	5.9%+1.0pp	4.9%+10.0pp	-5.2%	N/A
Current Ratio	0.82-0.1x	0.93-0.1x	0.99-0.2x	1.20+0.2x	0.97-0.2x	1.210.0x	1.26-0.2x	1.45+0.5x	0.98-0.5x	1.49	N/A
Debt-to-Equity	5.89+1.1x	4.79+2.1x	2.66-0.1x	2.79+0.7x	2.100.0x	2.07+1.0x	1.11+0.1x	0.97+0.5x	0.45-0.2x	0.63	N/A
Asset Turnover	1.57-0.2x	1.78-0.5x	2.30-0.1x	2.42+0.9x	1.56+0.4x	1.19-0.1x	1.33-0.5x	1.78+0.6x	1.22-0.2x	1.41	N/A
FCF Margin	0.1%+4.2pp	-4.2%-7.9pp	3.8%+3.0pp	0.7%-0.7pp	1.4%+9.0pp	-7.6%-9.3pp	1.7%-0.6pp	2.3%+0.3pp	2.0%-2.8pp	4.8%+5.0pp	-0.2%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-K	Q3'2510-K	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-K
Gross Margin	8.9%+7.0pp	-4.9%-2.5pp	N/A	13.8%+14.4pp	1.9%+1.4pp	-2.4%-5.4pp	N/A	-0.7%-6.7pp
Operating Margin	7.4%+8.6pp	-6.8%-2.0pp	6.8%+23.8pp	10.2%+14.3pp	-1.2%-1.4pp	-4.8%-5.7pp	-17.0%-13.3pp	-4.0%-8.6pp
Net Margin	4.2%+8.0pp	-7.6%-1.0pp	3.2%+20.7pp	6.2%+8.7pp	-3.9%-2.7pp	-6.5%-5.5pp	-17.4%-13.3pp	-2.5%-5.3pp
Return on Equity	40.1%+76.2pp	-66.7%-26.4pp	14.3%+86.3pp	40.0%+48.8pp	-36.1%-32.3pp	-40.2%-37.1pp	-71.9%-54.8pp	-8.8%-19.9pp
Return on Assets	2.2%+3.8pp	-2.7%-0.1pp	1.1%+7.4pp	2.5%+3.6pp	-1.5%-1.0pp	-2.5%-2.1pp	-6.2%-3.9pp	-1.1%-2.7pp
Current Ratio	0.760.0x	0.76-0.1x	0.82-0.1x	0.86-0.2x	0.80-0.2x	0.85-0.2x	0.93-0.1x	1.04-0.1x
Debt-to-Equity	7.53-3.0x	10.51+3.5x	5.89+1.1x	7.12+3.9x	10.48+8.0x	7.05+4.6x	4.79+2.1x	3.18+0.9x
Asset Turnover	0.54+0.2x	0.350.0x	0.350.0x	0.410.0x	0.39-0.1x	0.38-0.1x	0.36-0.2x	0.43-0.2x
FCF Margin	2.2%+6.3pp	10.3%+17.8pp	15.8%+30.7pp	-2.2%+2.4pp	-4.1%-0.3pp	-7.5%-11.6pp	-14.9%-15.4pp	-4.6%-13.0pp

Note: The current ratio is below 1.0 (0.82), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Delek US Holdings, Inc. DK	FY2025	$10.7B	-$22.8M	-0.2%	$4.7B	17/100
Par Pacific Holdings, Inc. PARR	FY2025	$7.5B	$369.4M	5.0%	$4.1B	48/100
World Kinect Corporation WKC	FY2025	$36.9B	-$614.4M	-1.7%	$1.9B	26/100
CrossAmerica Partners LP Common units CAPL	FY2025	$3.7B	$41.8M	1.1%	$816.9M	33/100
DELEK LOGISTICS PARTNERS, LP DKL	FY2025	$1.0B	$176.5M	17.4%	$3.3B	45/100
Star Group, L.P. Common Units SGU	FY2025	$1.8B	$73.5M	4.1%	$426.2M	44/100

Where Delek US Holdings, Inc. Ranks

Frequently Asked Questions

What is Delek US Holdings, Inc.'s annual revenue?

Delek US Holdings, Inc. (DK) reported $10.7B in total revenue for fiscal year 2025. This represents a -9.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Delek US Holdings, Inc.'s revenue growing?

Delek US Holdings, Inc. (DK) revenue declined by 9.5% year-over-year, from $11.9B to $10.7B in fiscal year 2025.

Is Delek US Holdings, Inc. profitable?

No, Delek US Holdings, Inc. (DK) reported a net income of -$22.8M in fiscal year 2025, with a net profit margin of -0.2%.

What is Delek US Holdings, Inc.'s EBITDA?

Delek US Holdings, Inc. (DK) had EBITDA of $698.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Delek US Holdings, Inc. have?

As of fiscal year 2025, Delek US Holdings, Inc. (DK) had $625.8M in cash and equivalents against $3.2B in long-term debt.

What is Delek US Holdings, Inc.'s gross margin?

Delek US Holdings, Inc. (DK) had a gross margin of 5.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Delek US Holdings, Inc.'s operating margin?

Delek US Holdings, Inc. (DK) had an operating margin of 2.8% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Delek US Holdings, Inc.'s net profit margin?

Delek US Holdings, Inc. (DK) had a net profit margin of -0.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Delek US Holdings, Inc. pay dividends?

Yes, Delek US Holdings, Inc. (DK) paid $1.02 per share in dividends during fiscal year 2025.

What is Delek US Holdings, Inc.'s return on equity (ROE)?

Delek US Holdings, Inc. (DK) has a return on equity of -4.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Delek US Holdings, Inc.'s free cash flow?

Delek US Holdings, Inc. (DK) generated $6.3M in free cash flow during fiscal year 2025. This represents a 101.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Delek US Holdings, Inc.'s operating cash flow?

Delek US Holdings, Inc. (DK) generated $535.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Delek US Holdings, Inc.'s total assets?

Delek US Holdings, Inc. (DK) had $6.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Delek US Holdings, Inc.'s capital expenditures?

Delek US Holdings, Inc. (DK) invested $529.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Delek US Holdings, Inc. have outstanding?

Delek US Holdings, Inc. (DK) had 60M shares outstanding as of fiscal year 2025.

What is Delek US Holdings, Inc.'s current ratio?

Delek US Holdings, Inc. (DK) had a current ratio of 0.82 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Delek US Holdings, Inc.'s debt-to-equity ratio?

Delek US Holdings, Inc. (DK) had a debt-to-equity ratio of 5.89 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Delek US Holdings, Inc.'s return on assets (ROA)?

Delek US Holdings, Inc. (DK) had a return on assets of -0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Delek US Holdings, Inc.'s P/E ratio?

Delek US Holdings, Inc. (DK) trades at 21.1x earnings, its market capitalization divided by net income of $224.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $4.7B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Delek US Holdings, Inc.'s price-to-sales ratio?

Delek US Holdings, Inc. (DK) trades at 0.4x sales, its market capitalization divided by revenue of $12.1B revenue, trailing 12 months to June 30, 2026. The market capitalization is $4.7B as of Oct 12, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Delek US Holdings, Inc.'s Altman Z-Score?

Delek US Holdings, Inc. (DK) has an Altman Z-Score of 2.02, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Delek US Holdings, Inc.'s Piotroski F-Score?

Delek US Holdings, Inc. (DK) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Delek US Holdings, Inc.'s earnings high quality?

Delek US Holdings, Inc. (DK) reported a net loss of $22.8M while generating $535.8M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Delek US Holdings, Inc. cover its interest payments?

Delek US Holdings, Inc. (DK) has an interest coverage ratio of 0.87x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Delek US Holdings, Inc.?

Delek US Holdings, Inc. (DK) scores 17 out of 100 on our Financial Health Score, indicating weak standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.